Equitable Holdings’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $684K | Buy |
60,814
+3,500
| +6% | +$39.4K | 0.01% | 915 |
|
|
2025
Q1 | $327K | Buy |
+57,314
| New | +$327K | ﹤0.01% | 1061 |
|
|
2024
Q3 | – | Sell |
-280
| Closed | -$3.74K | – | 1268 |
|
|
2024
Q2 | $3.74K | Sell |
280
-9
| -3% | -$120 | ﹤0.01% | 1210 |
|
|
2024
Q1 | $13.4K | Hold |
289
| – | – | ﹤0.01% | 1158 |
|
|
2023
Q4 | $19.5K | Hold |
289
| – | – | ﹤0.01% | 1127 |
|
|
2023
Q3 | $20.9K | Hold |
289
| – | – | ﹤0.01% | 1063 |
|
|
2023
Q2 | $21.5K | Hold |
289
| – | – | ﹤0.01% | 1035 |
|
|
2023
Q1 | $15.4K | Hold |
289
| – | – | ﹤0.01% | 972 |
|
|
2022
Q4 | $19.5K | Sell |
289
-25
| -8% | -$1.69K | ﹤0.01% | 895 |
|
|
2022
Q3 | $39K | Buy |
314
+9
| +3% | +$1.12K | ﹤0.01% | 859 |
|
|
2022
Q2 | $29K | Hold |
305
| – | – | ﹤0.01% | 848 |
|
|
2022
Q1 | $49K | Hold |
305
| – | – | ﹤0.01% | 864 |
|
|
2021
Q4 | $101K | Hold |
305
| – | – | ﹤0.01% | 846 |
|
|
2021
Q3 | $141K | Buy |
+305
| New | +$141K | ﹤0.01% | 821 |
|